🇺🇸 FDA
Patent

US 7932074

Multivalent human-bovine rotavirus vaccine

granted A61KA61K2039/545A61K2039/70

Quick answer

US patent 7932074 (Multivalent human-bovine rotavirus vaccine) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/545, A61K2039/70, A61K39/12, A61K39/15